The state of research and development in global cancer surgery

Annals of Surgery

Volumn 255, Issue 3, 2012, Pages 427-432

  Purushotham, Arnie D ^a,b   Lewison, Grant ^c   Sullivan, Richard ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CANCER SURGERY; CANCER THERAPY; FUNDING; PRIORITY JOURNAL; PUBLISHING;

HUMANS; INTERNATIONAL COOPERATION; NEOPLASMS; RESEARCH; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 84857649769     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318246591f     Document Type: Article

References (19)

1. Boyle P, Anderson BO, Andersson LC, et al. Need for global action for cancer control. Ann Oncol. 2008;19:1519-1521.
2. Eckhouse S, Lewison G, Sullivan R. Trends in the global funding and activity of cancer research. Molec Onc. 2008;2:20-32.
3. Jungbluth S, Kelm O, van de Loo J-W, et al. Europe combating cancer: The European Union's commitment to cancer research in the 6th Framework Programme. Molecular Oncology. 2007;1:14-18.
4. Sullivan R, Eckhouse S, Lewison G. Using bibliometrics to inform cancer research policy and spending. Monitoring Financial Flows 2007. Geneva, Switzerland: Global Forum for Health Research; 2008. 67-78.
5. Lewison G, Paraje G. The classification of biomedical journals by research level. Scientometrics. 2004;60:145-157.
6. Eckhouse S, Sullivan R. The state of academic cancer surgery in the UK. Molec Onc. 2008;2:206-212.
7. Cambrosio A, Keating P, Mercier S, et al. Mapping the emergence and development of translational cancer research. Eur J Cancer. 2006;42:3140-3148.
8. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372:139-144.
9. Majumdar SR, Chang WC, Armstrong PW. Do the investigative sites that take part in a positive clinical trial translate that evidence into practice? Am J Med. 2002;113:140-145.
10. Huang GJ, Mao YS, Zhang DC, et al. Current status and future directions of surgery for lung cancer in China. Chin Med J (Engl). 2007;120:619-621.
11. Burstein P. Policy domains: organization, culture, and policy outcomes. Ann Rev Sociol. 1991;17:327-350.
12. Lewison G. The percentage of reviews in research output: a simple measure of research esteem. Res Eval. 2009;18:25-37.
13. Gonzalez Block MA. The state of international collaboration for health systems research: what do publications tell us? Health Res Policy Syst. 2006;4:7.
14. Jackson HH, Jackson JD, Mulvihill SJ, et al. Trends in research support and productivity in the changing environment of academic surgery. J Surg Res. 2004;116:197-201.
15. Stuckler D, King L, Robinson H, et al. WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet. 2008;372:1563-1569.
16. Gouveia J, Coleman MP, Haward R, et al. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. Eur J Cancer. 2008;44:1457-1462.
17. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25:180-186.
18. Hitt E. The flat-funding years and the National Cancer Institute: consequences for cancer research. Mol Oncol. 2008;2:290-292.
19. Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol. 2004;16:549-560.